Key result
Poorer cardiovascular health is linked to interstitial lung disease as a potential upstream risk factor.
Why the study?
Previous studies show higher cardiovascular disease prevalence in interstitial lung disease but assess cardiovascular status only cross-sectionally after fibrosis develops, limiting understanding of cardiovascular health as an upstream risk factor for ILD.
Cardiovascular health is unproven as a modifiable interstitial lung disease risk factor; prospective studies needed before any clinical consideration.
Extract There are shared antecedent risk factors [1, 2] and pathobiological mechanisms [3] between pulmonary fibrosis and cardiovascular disease, suggesting these two distinct disease entities may be linked though common biological pathways. Studies consistently demonstrate a higher prevalence of cardiovascular disease among individuals with interstitial lung disease (ILD) [4]; however, these studies largely capture cardiovascular status at a single point, after pulmonary fibrosis has developed. This cross-sectional approach limits insight into whether cardiovascular health (CVH) truly represents an upstream risk factor for the development and progression of ILD.
No takes yet. Share an insight, caveat, or question.
Selvan et al. (2026) studied Interstitial lung disease. Cardiovascular health was evaluated. Cardiovascular health was discussed as a potential upstream risk factor for the development of interstitial lung disease, though the abstract provides no quantitative study results.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: